查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1771630

美国显影剂市场规模、份额、趋势分析报告（按产品、最终用途、类型、细分市场预测，2025-2030 年）

U.S. Contrast Media Injectors Market Size, Share & Trends Analysis Report By Product (Injector Systems, Consumables), By Application (Radiology, Interventional Cardiology), By Type, By End Use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

美国显影剂注射器市场的趋势：

预计 2024 年美国显影剂注射器市场规模将达到 6.0494 亿美元，2025 年至 2030 年的复合年增长率将达到 10.08%。

市场成长的动力来自于癌症、心血管疾病、神经系统疾病等慢性疾病的发生率上升。慢性疾病的增加推动了使用传统影像方式（如 X 光和超音波）以及先进影像技术（如电脑断层扫描和 MRI）进行诊断影像测试的需求。

受MRI、 电脑断层扫描和血管造影术等诊断影像需求成长的推动，北美显影剂注射器产业预计将经历显着成长。这种快速增长的驱动力源于影像技术的进步、人口老化、预防保健意识的增强以及慢性病的流行。医学影像对于各种疾病的早期发现、诊断和治疗计划至关重要。根据美国国家医学图书馆2023年10月发布的一项研究，美国每年约进行4000万次MRI扫描。

此外，美国疾病管制与预防中心 (CDC) 于 2024 年 2 月发布的数据显示，约有 1.29 亿美国至少患有一种主要慢性疾病。如此沉重的慢性疾病负担，加上每年进行的大量影像检查，凸显了对诊断影像学的强劲且不断增长的需求，进一步推动了全部区域输液设备显影剂的需求。因此，长期疾病和复杂合併症的盛行率不断上升是导致显影剂注射器需求增加的主要驱动因素之一。

预计显影剂注射器产品上市和监管审批的不断增加将显着推动市场成长。各公司正在引进无针注射器和多剂量注射器等先进技术，以提高效率和病患治疗效果。这些技术创新透过增强业务流程和支援更完善的诊断成像实践，推动了先进诊断成像系统的广泛应用。因此，对可靠有效的显影剂输送解决方案的需求持续成长，进一步推动了市场扩张。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国显影剂注射器市场变数、趋势与范围

  • 市场展望
    • 相关/支持市场展望
  • 使用者观点分析
    • 消费行为分析
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国显影剂注射器市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国显影剂注射器市场：产品评估与趋势分析

  • 定义和范围
  • 2018年及2030年产品市场占有率
  • 细分仪表板
  • 美国造影剂显影剂市场：产品展望
  • 2024年至2030年市场规模、预测与趋势分析
    • 喷射系统
    • 耗材

第五章美国显影剂注射器市场：类型评估与趋势分析

  • 定义和范围
  • 2018 年及 2030 年各类型市场占有率
  • 细分仪表板
  • 美国造影剂显影剂市场展望（按类型）
  • 2024年至2030年市场规模、预测与趋势分析
    • 单头注射器
    • 双头注射器
    • 无针注射器

第六章美国显影剂注射器市场：应用评估与趋势分析

  • 定义和范围
  • 2018 年和 2030 年应用市场占有率
  • 细分仪表板
  • 美国显影剂注射器市场：应用前景
  • 2024年至2030年市场规模、预测与趋势分析
    • 放射学
    • 介入性心臟病学
    • 介入放射学

第七章美国显影剂注射器市场：最终用途估计与趋势分析

  • 定义和范围
  • 2018 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 美国显影剂注射器市场：最终用途展望
  • 2024年至2030年市场规模、预测与趋势分析
    • 医院
    • 诊断中心
    • 门诊手术中心

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • Key customers
    • Key company market share analysis, 2024
    • Shenzhen Boon Medical Supply Co., Ltd.
    • Bracco Diagnostics Inc.
    • Bayer
    • Guerbet
    • ulrich GmbH &Co. KG
    • B.Braun SE
    • Shenzhen Antmed Co., Ltd.
    • Ecomed Solutions
    • Siemens Medical Solutions USA, Inc.（Siemens Healthineers AG）
Product Code: GVR-4-68040-231-5

U.S. Contrast Media Injectors Market Trends:

The U.S. contrast media injectors market size was estimated at USD 604.94 million in 2024 and is projected to grow at a CAGR of 10.08% from 2025 to 2030. The market growth is attributed to the rising incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders. The rising number of chronic diseases is driving the demand for diagnostic imaging tests that use conventional imaging methods such as X-rays and ultrasounds, along with advanced imaging techniques such as CT scans and MRIs.

The North America contrast media injectors industry is expected to grow significantly, driven by the rising demand for imaging procedures such as MRI, CT scans, and cardiovascular angiography. This surge is fueled by advancements in imaging technology, an aging population, increasing awareness of preventive healthcare, and the growing prevalence of chronic diseases. Medical imaging is critical in early detection, diagnosis, and treatment planning for a wide range of conditions. According to a study published by the National Library of Medicine in October 2023, nearly 40 million MRI scans are performed annually in the U.S.

In addition, data from the CDC in February 2024 revealed that approximately 129 million Americans are living with at least one major chronic illness. This substantial burden of chronic disease, combined with the high volume of imaging tests performed each year, highlights a strong and growing need for diagnostic imaging, further driving demand for contrast media injectors across the region. Hence, the increasing prevalence of long-term diseases and complex comorbidities is one of the major drivers, as it is leading to an increase in demand for contrast media injectors.

The growing number of product launches and regulatory approvals for contrast media injectors is expected to drive market growth significantly. Companies are introducing advanced technologies, including syringeless and multi-patient injectors, to improve efficiency and patient outcomes. These innovations enhance operational workflows and support better imaging practices, encouraging broader adoption of advanced imaging systems. As a result, the demand for reliable and effective contrast media delivery solutions continues to rise, further fueling market expansion.

U.S. Contrast Media Injectors Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. contrast media injectors market report based on product, type, application, and end use:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Injector Systems
    • CT injector systems
    • MRI injector systems
    • Cardiovascular/angiography injector systems
  • Consumables
    • Tubing
    • Syringe
    • Others
  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Single Head Injectors
  • Dual-Head Injectors
  • Syringeless Injectors
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Radiology
  • Interventional Cardiology
  • Interventional Radiology
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Diagnostics Centers
  • Ambulatory Surgery Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Third Party Perspective
    • 1.3.5. Primary research
    • 1.3.6. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights Outlook

Chapter 3. U.S. Contrast Media Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Related/ancillary market outlook.
  • 3.2. User Perspective Analysis
    • 3.2.1. Consumer behavior analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing demand for imaging tests
      • 3.3.1.2. Rising launches and approvals of contrast media injectors
      • 3.3.1.3. Increasing prevalence of chronic disorders
      • 3.3.1.4. Growing adoption of syringe less injectors
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Potential complications and risks associated with contrast media injections
    • 3.3.3. Market opportunity analysis
      • 3.3.3.1. Rising number of distribution agreements
      • 3.3.3.2. Advancements in contrast media injectors
      • 3.3.3.3. Growing clinical trials for contrast media and injectors
    • 3.3.4. Market challenge analysis
      • 3.3.4.1. Shortage of radiologists and healthcare professionals
  • 3.4. U.S. Contrast Media Injectors Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. U.S. Contrast Media Injectors Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. U.S. Contrast Media Injectors Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 4.5.1. Injector Systems
      • 4.5.1.1. Injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.2. CT injector systems
        • 4.5.1.2.1. CT injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.3. MRI injector systems
        • 4.5.1.3.1. MRI injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.4. Cardiovascular/angiography injector systems
        • 4.5.1.4.1. Cardiovascular/angiography injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Consumables
      • 4.5.2.1. Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.2. Syringes
        • 4.5.2.2.1. Syringes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.3. Tubings
        • 4.5.2.3.1. Tubings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.4. Others
        • 4.5.2.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Contrast Media Injectors Market: Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Type Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. U.S. Contrast Media Injectors Market by Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 5.5.1. Single Head Injectors
      • 5.5.1.1. Single head injectors market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Dual Head Injectors
      • 5.5.2.1. Dual head injectors market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Syringeless Injectors
      • 5.5.3.1. Syringeless injectors market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. Contrast Media Injectors Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Application Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. U.S. Contrast Media Injectors Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 6.5.1. Radiology
      • 6.5.1.1. Radiology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Interventional Cardiology
      • 6.5.2.1. Interventional cardiology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Interventional Radiology
      • 6.5.3.1. Interventional radiology market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. Contrast Media Injectors Market: End Use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. End Use Market Share, 2018 & 2030
  • 7.3. Segment Dashboard
  • 7.4. U.S. Contrast Media Injectors Market by End Use Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 7.5.1. Hospitals
      • 7.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Diagnostics Centers
      • 7.5.2.1. Diagnostics centers market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Ambulatory Surgery Centers
      • 7.5.3.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Shenzhen Boon Medical Supply Co., Ltd.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bracco Diagnostics Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bayer
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Guerbet
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. ulrich GmbH & Co. KG
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. B.Braun SE
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Shenzhen Antmed Co., Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Ecomed Solutions
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Siemens Medical Solutions USA, Inc. (Siemens Healthineers AG)
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. contrast media injectors market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. contrast media injectors market, by type, 2018 - 2030 (USD Million)
  • Table 5 U.S. contrast media injectors market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. contrast media injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Contrast media injectors market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's Five Forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 U.S. Contrast media injectors market: Product movement analysis
  • Fig. 19 U.S. Contrast media injectors market: Product Segment dashboard
  • Fig. 20 U.S. Contrast media injectors market product outlook: Key takeaways
  • Fig. 21 U.S. Injector systems market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. CT injector systems market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. MRI injector systems market, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Cardiovascular/angiography injector systems market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Consumables market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Syringes market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Tubings market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Contrast media injectors market: Type movement analysis
  • Fig. 30 U.S. Contrast media injectors market: Type Segment dashboard
  • Fig. 31 U.S. Contrast media injectors market type outlook: Key takeaways
  • Fig. 32 U.S. Single head injectors market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Dual head injectors market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Syringeless injectors market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Contrast media injectors market: Application movement analysis
  • Fig. 36 U.S. Contrast media injectors market: Application Segment dashboard
  • Fig. 37 U.S. Contrast media injectors market application outlook: Key takeaways
  • Fig. 38 U.S. Radiology market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Interventional cardiology market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Interventional radiology market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Contrast media injectors market: End use movement analysis
  • Fig. 42 U.S. Contrast media injectors market: End use Segment dashboard
  • Fig. 43 U.S. Contrast media injectors market end use outlook: Key takeaways
  • Fig. 44 U.S. Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Diagnostics centres market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Ambulatory surgery centers market, 2018 - 2030 (USD Million)
  • Fig. 47 Company market share analysis, 2024
  • Fig. 48 Market differentiators